Global Systemic Scleroderma Treatment Market Size, Share, and COVID-19 Impact Analysis By Drug Class (Immunosuppressors, Calcium Channel Blockers, Proton Pump Inhibitors, Phosphodiesterase 5 Inhibitors, Endothelin Receptor Antagonists, Prostacyclin Analogues, and Others), By Disease Type (limited Systemic Sclerosis, Diffused Systemic Sclerosis, and Systemic Sclerosis Sine Scleroderma), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030.

Industry: Healthcare
RELEASE DATE Oct 2022
REPORT ID SI1224
PAGES 215
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Drug Class Type
      2. Market Attractiveness Analysis  By Disease Type
      3. Market Attractiveness Analysis  By Administration Type
      4. Market Attractiveness Analysis  By Channel Type
      5. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Increasing prevalence of scleroderma
    3. Restraints
      1. Lack of a standard framework for evaluating systemic scleroderma therapeutics
    4. Opportunities
      1. Increasing products approval and launches by market players
    5. Challenges
      1. Failure of clinical trials associated with the development of systemic scleroderma therapeutics
  6. Global Systemic Scleroderma Treatment Market Analysis and Projection, By Drug Class Type
    1. Segment Overview
    2. Immunosuppressants
    3. Calcium channel blockers
    4. Proton pump inhibitors
    5. Glucocorticoids
    6. Alkylating agents
    7. Interleukin inhibitors
    8. Others
  7. Global Systemic Scleroderma Treatment Market Analysis and Projection,  By Disease Type
    1. Segment Overview
    2. Limited systemic sclerosis
    3. Generalized systemic sclerosis
    4. Systemic sclerosis sine scleroderma
  8. Global Systemic Scleroderma Treatment Market Analysis and Projection, By Administration Type
    1. Segment Overview
    2. Oral
    3. Parenteral
  9. Global Systemic Scleroderma Treatment Market Analysis and Projection, By Channel Type
    1. Segment Overview
    2. Hospital Pharmacies
    3. Retail Pharmacies
    4. Online Pharmacies
  10. Global Systemic Scleroderma Treatment Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  11. Global Systemic Scleroderma Treatment Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Systemic Scleroderma Treatment Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  12. Company Profiles
    1. Bristol-Myers Squibb Company
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
  13. Boehringer Ingelheim International GmbH
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  14. Allergan
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  15. Actelion Pharmaceuticals Ltd
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  16. F. Hoffmann-La Roche Ltd
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  17. GlaxoSmithKline plc.
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  18. Biogen
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  19. Novartis AG
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  20. Teva Pharmaceutical Industries Ltd.
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  21. AstraZeneca
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis

List of Table

  1. Global Systemic Scleroderma Treatment Market, By Drug Class Type, 2021-2030(USD Billion)
  2. Global Immunosuppressants Systemic Scleroderma Treatment Market, By Region, 2021-2030(USD Billion)
  3. Global Calcium channel blockers Systemic Scleroderma Treatment Market, By Region, 2021-2030(USD Billion)
  4. Global Proton pump inhibitors Systemic Scleroderma Treatment Market, By Region, 2021-2030(USD Billion)
  5. Global Glucocorticoids Systemic Scleroderma Treatment Market, By Region, 2021-2030(USD Billion)
  6. Global Alkylating agents Systemic Scleroderma Treatment Market, By Region, 2021-2030(USD Billion)
  7. Global Interleukin inhibitors Systemic Scleroderma Treatment Market, By Region, 2021-2030(USD Billion)
  8. Global others  Systemic Scleroderma Treatment Market, By Region, 2021-2030(USD Billion)
  9. Global Systemic Scleroderma Treatment Market,  By Disease Type, 2021-2030(USD Billion)
  10. Global Limited systemic sclerosis Systemic Scleroderma Treatment Market, By Region, 2021-2030(USD Billion)
  11. Global Generalized systemic sclerosis Systemic Scleroderma Treatment Market, By Region, 2021-2030(USD Billion)
  12. Global Systemic sclerosis sine scleroderma Systemic Scleroderma Treatment Market, By Region, 2021-2030(USD Billion)
  13. Global Systemic Scleroderma Treatment Market, By Administration Type, 2021-2030(USD Billion)
  14. Global Oral Systemic Scleroderma Treatment Market, By Region, 2021-2030(USD Billion)
  15. Global Parenteral Systemic Scleroderma Treatment Market, By Region, 2021-2030(USD Billion)
  16. Global Systemic Scleroderma Treatment Market, By Channel Type, 2021-2030(USD Billion)
  17. Global Hospital Pharmacies Systemic Scleroderma Treatment Market, By Region, 2021-2030(USD Billion)
  18. Global Retail Pharmacies Systemic Scleroderma Treatment Market, By Region, 2021-2030(USD Billion)
  19. Global Online Pharmacies Systemic Scleroderma Treatment Market, By Region, 2021-2030(USD Billion)
  20. North America Systemic Scleroderma Treatment Market, By Drug Class Type, 2021-2030(USD Billion)
  21. North America Systemic Scleroderma Treatment Market,  By Disease Type, 2021-2030(USD Billion)
  22. North America Systemic Scleroderma Treatment Market, By Administration Type, 2021-2030(USD Billion)
  23. North America Systemic Scleroderma Treatment Market, By Channel Type, 2021-2030(USD Billion)
  24. U.S. Systemic Scleroderma Treatment Market, By Drug Class Type, 2021-2030(USD Billion)
  25. U.S. Systemic Scleroderma Treatment Market,  By Disease Type, 2021-2030(USD Billion)
  26. U.S. Systemic Scleroderma Treatment Market,  By Administration Type, 2021-2030(USD Billion)
  27. U.S. Systemic Scleroderma Treatment Market,  By Channel Type, 2021-2030(USD Billion)
  28. Canada Systemic Scleroderma Treatment Market, By Drug Class Type, 2021-2030(USD Billion)
  29. Canada Systemic Scleroderma Treatment Market,  By Disease Type, 2021-2030(USD Billion)
  30. Canada Systemic Scleroderma Treatment Market,  By Administration Type, 2021-2030(USD Billion)
  31. Canada Systemic Scleroderma Treatment Market,  By Channel Type, 2021-2030(USD Billion)
  32. Mexico Systemic Scleroderma Treatment Market, By Drug Class Type, 2021-2030(USD Billion)
  33. Mexico Systemic Scleroderma Treatment Market,  By Disease Type, 2021-2030(USD Billion)
  34. Mexico Systemic Scleroderma Treatment Market,  By Administration Type, 2021-2030(USD Billion)
  35. Mexico Systemic Scleroderma Treatment Market,  By Channel Type, 2021-2030(USD Billion)
  36. Europe Systemic Scleroderma Treatment Market, By Drug Class Type, 2021-2030(USD Billion)
  37. Europe Systemic Scleroderma Treatment Market,  By Disease Type, 2021-2030(USD Billion)
  38. Europe Systemic Scleroderma Treatment Market,  By Administration Type, 2021-2030(USD Billion)
  39. Europe Systemic Scleroderma Treatment Market,  By Channel Type, 2021-2030(USD Billion)
  40. Germany Systemic Scleroderma Treatment Market, By Drug Class Type, 2021-2030(USD Billion)
  41. Germany Systemic Scleroderma Treatment Market,  By Disease Type, 2021-2030(USD Billion)
  42. Germany Systemic Scleroderma Treatment Market,  By Administration Type, 2021-2030(USD Billion)
  43. Germany Systemic Scleroderma Treatment Market,  By Channel Type, 2021-2030(USD Billion)
  44. France Systemic Scleroderma Treatment Market, By Drug Class Type, 2021-2030(USD Billion)
  45. France Systemic Scleroderma Treatment Market,  By Disease Type, 2021-2030(USD Billion)
  46. France Systemic Scleroderma Treatment Market,  By Administration Type, 2021-2030(USD Billion)
  47. France Systemic Scleroderma Treatment Market,  By Channel Type, 2021-2030(USD Billion)
  48. U.K. Systemic Scleroderma Treatment Market, By Drug Class Type, 2021-2030(USD Billion)
  49. U.K. Systemic Scleroderma Treatment Market,  By Disease Type, 2021-2030(USD Billion)
  50. U.K Systemic Scleroderma Treatment Market,  By Administration Type, 2021-2030(USD Billion)
  51. U.K Systemic Scleroderma Treatment Market,  By Channel Type, 2021-2030(USD Billion)
  52. Italy Systemic Scleroderma Treatment Market, By Drug Class Type, 2021-2030(USD Billion)
  53. Italy Systemic Scleroderma Treatment Market,  By Disease Type, 2021-2030(USD Billion)
  54. Italy Systemic Scleroderma Treatment Market,  By Administration Type, 2021-2030(USD Billion)
  55. Italy Systemic Scleroderma Treatment Market,  By Channel Type, 2021-2030(USD Billion)
  56. Spain Systemic Scleroderma Treatment Market, By Drug Class Type, 2021-2030(USD Billion)
  57. Spain Systemic Scleroderma Treatment Market,  By Disease Type, 2021-2030(USD Billion)
  58. Spain Systemic Scleroderma Treatment Market,  By Administration Type, 2021-2030(USD Billion)
  59. Spain Systemic Scleroderma Treatment Market,  By Channel Type, 2021-2030(USD Billion)
  60. Asia Pacific Systemic Scleroderma Treatment Market, By Drug Class Type, 2021-2030(USD Billion)
  61. Asia Pacific Systemic Scleroderma Treatment Market,  By Disease Type, 2021-2030(USD Billion)
  62. Asia Systemic Scleroderma Treatment Market,  By Administration Type, 2021-2030(USD Billion)
  63. Asia Systemic Scleroderma Treatment Market,  By Channel Type, 2021-2030(USD Billion)
  64. Japan Systemic Scleroderma Treatment Market, By Drug Class Type, 2021-2030(USD Billion) 
  65. Japan Systemic Scleroderma Treatment Market,  By Disease Type, 2021-2030(USD Billion)
  66. Japan Systemic Scleroderma Treatment Market,  By Administration Type, 2021-2030(USD Billion)
  67. Japan Systemic Scleroderma Treatment Market,  By Channel Type, 2021-2030(USD Billion)
  68. China Systemic Scleroderma Treatment Market, By Drug Class Type, 2021-2030(USD Billion) 
  69. China Systemic Scleroderma Treatment Market,  By Disease Type, 2021-2030(USD Billion)
  70. China Systemic Scleroderma Treatment Market,  By Administration Type, 2021-2030(USD Billion)
  71. Chain Systemic Scleroderma Treatment Market,  By Channel Type, 2021-2030(USD Billion)
  72. India Systemic Scleroderma Treatment Market, By Drug Class Type, 2021-2030(USD Billion)
  73. India Systemic Scleroderma Treatment Market,  By Disease Type, 2021-2030(USD Billion)
  74. India Systemic Scleroderma Treatment Market,  By Administration Type, 2021-2030(USD Billion)
  75. India Systemic Scleroderma Treatment Market,  By Channel Type, 2021-2030(USD Billion)
  76. South America Systemic Scleroderma Treatment Market, By Drug Class Type, 2021-2030(USD Billion)
  77. South America Systemic Scleroderma Treatment Market,  By Disease Type, 2021-2030(USD Billion)
  78. South America Systemic Scleroderma Treatment Market, By Administration Type, 2021-2030(USD Billion)
  79. South America Systemic Scleroderma Treatment Market,  By Channel Type, 2021-2030(USD Billion) 
  80. Brazil Systemic Scleroderma Treatment Market, By Drug Class Type, 2021-2030(USD Billion)
  81. Brazil Systemic Scleroderma Treatment Market,  By Disease Type, 2021-2030(USD Billion)
  82. Brazil Systemic Scleroderma Treatment Market,  By Administration Type, 2021-2030(USD Billion)
  83. Brazil Systemic Scleroderma Treatment Market,  By Channel Type, 2021-2030(USD Billion)
  84. The Middle East and Africa Systemic Scleroderma Treatment Market, By Drug Class Type, 2021-2030(USD Billion)
  85. The Middle East and Africa Systemic Scleroderma Treatment Market,  By Disease Type, 2021-2030(USD Billion)
  86. The Middle East and Africa Smal Systemic Scleroderma Treatment Market,  By Administration Type, 2021-2030(USD Billion)
  87. The Middle East and Africa Smal Systemic Scleroderma Treatment Market,  By Channel Type, 2021-2030(USD Billion)
  88. UAE Systemic Scleroderma Treatment Market, By Drug Class Type, 2021-2030(USD Billion)
  89. UAE Systemic Scleroderma Treatment Market,  By Disease Type, 2021-2030(USD Billion)
  90. UAE Systemic Scleroderma Treatment Market,  By Administration Type, 2021-2030(USD Billion)
  91. UAE Systemic Scleroderma Treatment Market,  By Channel Type, 2021-2030(USD Billion)
  92. South Africa Systemic Scleroderma Treatment Market, By Drug Class Type, 2021-2030(USD Billion)
  93. South Africa Systemic Scleroderma Treatment Market, By Disease Type, 2021-2030(USD Billion)
  94. South Africa Systemic Scleroderma Treatment Market,  By Administration Type, 2021-2030(USD Billion)
  95. South Africa Systemic Scleroderma Treatment Market, By Channel Type, 2021-2030(USD Billion)

 

List of Figures 

  1. Global Systemic Scleroderma Treatment Market Segmentation
  2. Systemic Scleroderma Treatment Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Systemic Scleroderma Treatment Market
  9. Top Winning Strategies, 2021-2030
  10. Top Winning Strategies, By Development, 2021-2030(%)
  11. Top Winning Strategies, By Company, 2021-2030
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2022
  18. Market Share Analysis, 2022
  19. Restraint and Drivers: Systemic Scleroderma Treatment Market
  20. Systemic Scleroderma Treatment Market Segmentation, By Drug Class Type
  21. Systemic Scleroderma Treatment Market For Immunosuppressants, By Region, 2022-2030 ($Billion)
  22. Systemic Scleroderma Treatment Market For Calcium channel blockers, By Region, 2022-2030 ($Billion)
  23. Systemic Scleroderma Treatment Market For Proton pump inhibitors, By Region, 2022-2030 ($Billion)
  24. Systemic Scleroderma Treatment Market For Glucocorticoids, By Region, 2022-2030 ($Billion)
  25. Systemic Scleroderma Treatment Market For Alkylating agents, By Region, 2022-2030 ($Billion)
  26. Systemic Scleroderma Treatment Market For Interleukin inhibitors, By Region, 2022-2030 ($Billion)
  27. Systemic Scleroderma Treatment Market For others, By Region, 2022-2030 ($Billion)
  28. Systemic Scleroderma Treatment Market Segmentation,  By Disease Type
  29. Systemic Scleroderma Treatment Market For Limited systemic sclerosis, By Region, 2022-2030 ($Billion)
  30. Systemic Scleroderma Treatment Market For Generalized systemic sclerosis, By Region, 2022-2030 ($Billion)
  31. Systemic Scleroderma Treatment Market For Systemic sclerosis sine scleroderma, By Region, 2022-2030 ($Billion)
  32. Systemic Scleroderma Treatment Market Segmentation, By Administration Type
  33. Systemic Scleroderma Treatment Market For Oral, By Region, 2022-2030 ($Billion)
  34. Systemic Scleroderma Treatment Market For Parenteral, By Region, 2022-2030 ($Billion)
  35. Systemic Scleroderma Treatment Market Segmentation,  By Channel Type
  36. Systemic Scleroderma Treatment Market For Hospital Pharmacies, By Region, 2022-2030 ($Billion)
  37. Systemic Scleroderma Treatment Market For Retail Pharmacies, By Region, 2022-2030 ($Billion)
  38. Systemic Scleroderma Treatment Market For Online Pharmacies, By Region, 2022-2030 ($Billion)
  39. Procter & Gamble: Net Sales, 2021-2030 ($Billion)
  40. Procter & Gamble: Revenue Share, By Segment, 2022 (%)
  41. Procter & Gamble: Revenue Share, By Region, 2022 (%)
  42. PHYTOMER: Net Sales, 2021-2030 ($Billion)
  43. PHYTOMER: Revenue Share, By Segment, 2022 (%)
  44. PHYTOMER: Revenue Share, By Region, 2022 (%)
  45. Deka Corporation: Net Sales, 2021-2030 ($Billion)
  46. Deka Corporation: Revenue Share, By Segment, 2022 (%)
  47. Deka Corporation: Revenue Share, By Region, 2022 (%)
  48. Johnson & Johnson: Net Sales, 2021-2030 ($Billion)
  49. Johnson & Johnson: Revenue Share, By Segment, 2022 (%)
  50. Johnson & Johnson: Revenue Share, By Region, 2022 (%)
  51. Unilever Plc.: Net Sales, 2021-2030 ($Billion)
  52. Unilever Plc.: Revenue Share, By Segment, 2022 (%)
  53. Unilever Plc.: Revenue Share, By Region, 2022 (%)
  54. Kao Corporation: Net Sales, 2021-2030 ($Billion)
  55. Kao Corporation: Revenue Share, By Segment, 2022 (%)
  56. Kao Corporation: Revenue Share, By Region, 2022 (%)
  57. ZO Skin Health, Inc.: Net Sales, 2021-2030 ($Billion)
  58. ZO Skin Health, Inc.: Revenue Share, By Segment, 2022 (%)
  59. ZO Skin Health, Inc.: Revenue Share, By Region, 2022 (%)
  60. L’Oreal Paris: Net Sales, 2021-2030 ($Billion)
  61. L’Oreal Paris: Revenue Share, By Segment, 2022 (%)
  62. L’Oreal Paris: Revenue Share, By Region, 2022 (%)
  63. Shiseido Company Limited: Net Sales, 2021-2030 ($Billion)
  64. Shiseido Company Limited: Revenue Share, By Segment, 2022 (%)
  65. Shiseido Company Limited: Revenue Share, By Region, 2022 (%)
  66. Estee Lauder Companies, Inc.: Net Sales, 2021-2030 ($Billion)
  67. Estee Lauder Companies, Inc.: Revenue Share, By Segment, 2022 (%)
  68. Estee Lauder Companies, Inc.: Revenue Share, By Region, 2022 (%)

 

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2021
Tables & Figures:163
Pages:215
Countries covered:17
Companies covered::20
Forecast CAGR:4.5%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies